Zydus Lifesciences announced that Usnoflast, a treatment for amyotrophic lateral sclerosis (ALS), has received Orphan Drug Designation from the US FDA. This designation supports the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback